Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29551 - 29575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	EPHX1	2052	upregulated	decitabine results in increased expression of EPHX1 mRNA	1q42.12	A20985
Decitabine	Approved Investigational	EPHX3	79852	upregulated	decitabine results in increased expression of EPHX3 mRNA	19p13.12	A21919
Decitabine	Approved Investigational	EPO	2056	upregulated	decitabine results in increased expression of EPO mRNA	7q22.1	A20985
Decitabine	Approved Investigational	ERCC1	2067	downregulated	decitabine results in decreased expression of ERCC1 mRNA	19q13.32	A21181
Decitabine	Approved Investigational	ERCC6	2074	upregulated	decitabine results in increased expression of ERCC6 mRNA	10q11.23	A21181
Decitabine	Approved Investigational	ERG	2078	upregulated	decitabine results in increased expression of ERG mRNA	21q22.2	A20985
Decitabine	Approved Investigational	ERG	2078	upregulated	decitabine results in increased expression of ERG mRNA alternative form	21q22.2	A21971
Decitabine	Approved Investigational	ERRFI1	54206	upregulated	decitabine results in increased expression of ERRFI1 mRNA	1p36.23	A21930
Decitabine	Approved Investigational	ESAM	90952	upregulated	decitabine results in increased expression of ESAM mRNA	11q24.2	A21915
Decitabine	Approved Investigational	ESR1	2099	downregulated	decitabine results in decreased expression of ESR1 mRNA	6q25.1-q25.2	A21972 A21197
Decitabine	Approved Investigational	ESR1	2099	upregulated	decitabine results in increased expression of ESR1 mRNA	6q25.1-q25.2	A21973 A21974 A21918
Decitabine	Approved Investigational	ESR2	2100	downregulated	decitabine results in decreased expression of ESR2 mRNA	14q23.2-q23.3	A21197
Decitabine	Approved Investigational	ESR2	2100	upregulated	decitabine results in increased expression of ESR2 mRNA	14q23.2-q23.3	A21975 A21976
Decitabine	Approved Investigational	ETS1	2113	upregulated	decitabine results in increased expression of ETS1 mRNA	11q24.3	A21956
Decitabine	Approved Investigational	F2R	2149	upregulated	decitabine results in increased expression of F2R mRNA	5q13.3	A21919
Decitabine	Approved Investigational	FADS1	3992	upregulated	decitabine results in increased expression of FADS1 mRNA	11q12.2	A21919 A21917
Decitabine	Approved Investigational	FAM111A	63901	upregulated	decitabine results in increased expression of FAM111A mRNA	11q12.1	A20985
Decitabine	Approved Investigational	FAM149B1	317662	upregulated	decitabine results in increased expression of FAM149B1 mRNA	10q22.2	A20985
Decitabine	Approved Investigational	FAM8A1	51439	upregulated	decitabine results in increased expression of FAM8A1 mRNA	6p22.3	A20985
Decitabine	Approved Investigational	FATE1	89885	upregulated	decitabine results in increased expression of FATE1 mRNA	Xq28	A21955
Decitabine	Approved Investigational	FBXO41	150726	downregulated	decitabine results in decreased expression of FBXO41 mRNA	2p13.2	A20985
Decitabine	Approved Investigational	FCER1G	2207	upregulated	decitabine results in increased expression of FCER1G mRNA	1q23.3	A20985
Decitabine	Approved Investigational	FCGBP	8857	upregulated	decitabine results in increased expression of FCGBP mRNA	19q13.2	A21919
Decitabine	Approved Investigational	FGFR1	2260	downregulated	decitabine results in decreased expression of FGFR1 mRNA	8p11.23	A21930
Decitabine	Approved Investigational	FILIP1	27145	upregulated	decitabine results in increased expression of FILIP1 mRNA	6q14.1	A21919

Displaying entries 29551 - 29575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability